Trifecta Capital Advisors »

ResMed shares owned by Trifecta Capital Advisors

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Trifecta Capital Advisors from 13F filings

Historical chart of Trifecta Capital Advisors investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Trifecta Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Trifecta Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4k 7 198.14
2023-12-31 $1.2k 7 172.14

More positions owned by Trifecta Capital Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Costco Wholesale Corporation (COST)
Ishares Tr Core S&p Mcp Etf (IJH)
Palo Alto Networks (PANW)
Caterpillar (CAT)

View all positions for Trifecta Capital Advisors

Top funds holding ResMed

Vanguard Group
Bank of New York Mellon
Norges Bank Investment Management
Legal & General Group
Charles Schwab Investment Management
Jpmorgan Chase & Co
Goldman Sachs Group
Lgt Capital Partners
Amundi
Ubs Global Asset Management Americas
Congress Asset Management
Zurich Insurance Group Ltd/FI
Dimensional Fund Advisors
Citadel Advisors
Jane Street

View all funds holding ResMed